That would be nice if it can happen. But when a massive short squeeze happens just like when FDA approval of Provenge in 2010, selling all or half was a fantastic idea for traders/long term investors alike. Even AAPL with a spectacular growth performance do suffers short term declines before they recover.
The only quick returns I can see is a buy out with at least 100%+ premium of current pps, otherwise it will be a long wait for other catalyst. It will take years to expand use of Provenge because Clinical trials takes a lot money and time. EEU sales partnership or expansion is yet to be realized and even if it does take hold, it takes more time to increase revenue.
In short, my investing thesis as a "small retail investor", buy the dips and sell the rips while holding a small core position. Right now I hold a small position and several future call options contracts for $5-6 target price. GL.